ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,78
-0,78%
Dow Jones
39 839,93
0,08%
DAX
18 701,30
-0,35%
Brent Oil
82,985
-0,65%
Bitcoin
70 200,82
-1,75%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PharmaCyte Biotech Inc (PMCB)

  7. PharmaCyte Biotech Inc (PMCB) Actualités

PMCB

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PMCB
DateHeureSourceTitreSymboleSociété
21/05/202415h00Business WirePharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory DiseaseNASDAQ:PMCBPharmaCyte Biotech Inc
14/02/202421h38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMCBPharmaCyte Biotech Inc
06/02/202415h56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
15/12/202323h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
28/11/202323h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
24/11/202322h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202323h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202322h00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PMCBPharmaCyte Biotech Inc
15/11/202314h30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:PMCBPharmaCyte Biotech Inc
31/10/202314h15Business WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
02/10/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PMCBPharmaCyte Biotech Inc
21/09/202323h04Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
15/09/202323h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202323h18Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202322h42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
19/07/202316h28Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
16/06/202323h23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PMCBPharmaCyte Biotech Inc
15/06/202322h02Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:PMCBPharmaCyte Biotech Inc
15/06/202315h15Business WirePharmaCyte Biotech Announces Final Results of Tender OfferNASDAQ:PMCBPharmaCyte Biotech Inc
05/06/202322h06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PMCBPharmaCyte Biotech Inc
25/05/202323h14Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PMCBPharmaCyte Biotech Inc
19/05/202323h20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PMCBPharmaCyte Biotech Inc
11/05/202314h30Business WirePharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per ShareNASDAQ:PMCBPharmaCyte Biotech Inc
16/03/202321h43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PMCBPharmaCyte Biotech Inc
14/02/202322h52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PMCBPharmaCyte Biotech Inc
02/02/202315h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PMCBPharmaCyte Biotech Inc
02/02/202315h00Business WirePharmaCyte Biotech to Implement Second $10-Million Share Repurchase PlanNASDAQ:PMCBPharmaCyte Biotech Inc
30/12/202222h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PMCBPharmaCyte Biotech Inc
30/12/202222h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PMCBPharmaCyte Biotech Inc
11/10/202210h45TipRanksH.C. Wainwright Keeps Their Hold Rating on PharmaCyte Biotech (PMCB)NASDAQ:PMCBPharmaCyte Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:PMCB

Dernières Valeurs Consultées

LSE
ARW3
3x Ark Internet
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés